Biora Therapeutics (BIOR) PT Raised to $23 at H.C. Wainwright Nov 18, 2024 06:56AM
Biora Therapeutics (BIOR) Misses Q3 EPS by 504c Nov 14, 2024 05:13PM
Biora Therapeutics (BIOR) Prices 745K Share Offering at $4.025/sh Oct 29, 2024 08:00AM
Biora Therapeutics (BIOR) Shares Progress on Smaller BioJet Clinical Device with Largest Payload of any Ingestible Injectable Oct 28, 2024 08:09AM
Biora Therapeutics (BIOR) Announces Positive Nasdaq Listing Decision Aug 28, 2024 08:02AM


Aug 13, 2024 06:05AM H.C. Wainwright Reiterates Buy Rating on Biora Therapeutics (BIOR)
Jul 18, 2024 08:04AM Biora Therapeutics (BIOR) Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
Jul 1, 2024 08:00AM Biora Therapeutics (BIOR) Announces Positive Clinical Trial Results for BT-600